Authors: SOTANIEMI EA ANTTILA MI

Citation: Ea. Sotaniemi et Mi. Anttila, INFLUENCE OF AGE ON TOREMIFENE PHARMACOKINETICS, Cancer chemotherapy and pharmacology, 40(2), 1997, pp. 185-188

Authors: HEINONEN EH ANTTILA MI NYMAN LM PYYKKO KA VUORINEN JA LAMMINTAUSTA RAS

Citation: Eh. Heinonen et al., INHIBITION OF PLATELET MONOAMINE-OXIDASE TYPE-B BY SELEGILINE, Journal of clinical pharmacology, 37(7), 1997, pp. 597-601

Authors: HEINONEN EH ANTTILA MI KARNANI HL NYMAN LM VUORINEN JA PYYKKO KA LAMMINTAUSTA RAS

Citation: Eh. Heinonen et al., DESMETHYLSELEGILINE, A METABOLITE OF SELEGILINE, IS AN IRREVERSIBLE INHIBITOR OF MONOAMINE-OXIDASE TYPE-B IN HUMANS, Journal of clinical pharmacology, 37(7), 1997, pp. 602-609

Authors: HEINONEN EH ANTTILA MI LAMMINTAUSTA RAS

Citation: Eh. Heinonen et al., PHARMACOKINETIC ASPECTS OF L-DEPRENYL (SELEGILINE) AND ITS METABOLITES, Clinical pharmacology and therapeutics, 56(6), 1994, pp. 742-749